Composition for contraception

Details Composition for contraception Composition for contraception

1994-06-30

1996-12-10

Spivack, Phyllis G.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Cyclopentanohydrophenanthrene ring system doai

514173, 514182, A61K 3156, A61K 3157, A61K 31585

Patent

active

055831290

ABSTRACT:
This invention relates to a method of inducing contraception comprising administering an estrogen selected from

REFERENCES:
Parke Davis package insert for Loestrin, Jun., 1993.
G. B. Melis, et al., Contraception, "A Comparative Study on the Effects fo a Monophasic Pill Containing Desogestrel Plus 20 .mu.g Ethinylestradiol, a Triphasic Combination Containing Levonorgestrel and a Monophasic Combination Containign gestrodene on Coagulatory Factors", vol. 43, No. 1, pp. 23-30 (Jan. 1991).
A. R. Genazzani, et al. (Ed), Progress in Gynecology and Obstetrics, "Multicenter Clinical Trial on the new Oral Contraceptive 20 .mu.g Ethinylestradiol", Chapter 1, pp. 747-756, (1990).

Affiliated with

Also associated with

Rating

Composition for contraception does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition for contraception, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition for contraception will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-424334